Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Treatment of Cryptosporidium: What We Know, Gaps, and the Way Forward
Hayley Sparks
, Gayatri Nair
,
Alejandro Castellanos-Gonzalez
,
A. Clinton White
Internal Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
117
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of Cryptosporidium: What We Know, Gaps, and the Way Forward'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
AIDS Patients
100%
Antiparasitic Treatment
50%
Childhood Diarrhea
50%
Childhood Malnutrition
50%
Cryptosporidiosis
100%
Cryptosporidium
100%
Cryptosporidium Infection
50%
Disease Burden
50%
Drug Repurposing
50%
Global Health
50%
Health Anxiety
50%
Immune Reconstitution
50%
Immunocompromised Patients
100%
Immunosuppression
50%
Nitazoxanide
50%
Public Health Risk
50%
Transplant Patients
50%
Treatment Limitation
50%
Treatment Options
50%
Medicine and Dentistry
Antiparasitic Therapy
33%
Clinical Study
33%
Cryptosporidiosis
100%
Diarrhea
33%
Diseases
33%
Hope
33%
Immune Reconstitution
33%
Immunocompromised Patient
66%
Immunosuppressive Treatment
33%
Nitazoxanide
33%
Public Health
33%
Treatment Option
33%